Glut1 deficiency syndrome is a rare and disabling neurological disease still relatively unknown to the medical community. A mutation in the SLC2A1 gene in affected patients causes the glucose ...
TWIST1 is a major regulator of epithelial mesenchymal transition process, essential in cancer metastasis. Cancer cells increase glucose uptake capabilities to meet their high energy requirements. In ...
Larry Louters,Gunnink S.M.,Kerk S.A.,Kuiper B.D.,Alabi O.D.,Kuipers D.P.,Praamsma R.C.,Wrobel K.E.
Blocking a pair of sugar-transporting proteins may be a useful treatment approach for lung cancer, suggests a new study in mice and human cells published today in eLife. Cancer cells use a lot of ...
There is now a blood test that can diagnose a rare neurometabolic condition known as Glut1 deficiency syndrome, or De Vivo disease. Glut1 deficiency syndrome is caused by a mutation in a gene called ...
The studies, led by researchers at Lund University in Sweden, were carried out on cancer cells in a lab environment. The results were recently published in the research journal Haematologica. Just ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback